Clendeninn Neil James 4
4 · ONCOGENEX PHARMACEUTICALS, INC. · Filed Aug 7, 2012
Insider Transaction Report
Form 4
Clendeninn Neil James
Director
Transactions
- Exercise/Conversion
Common Stock
2012-08-03$4.11/sh+3,702$15,197→ 7,049 total - Exercise/Conversion
Stock Option
2012-08-03−3,702→ 0 totalExercise: $4.11From: 2005-08-08Exp: 2012-08-08→ Common Stock (3,702 underlying)